Charrow A. Hidradenitis suppurativa for the dermatologic hospitalist. Cutis. 2019;104(5):276–80.

PubMed  Google Scholar 

Edigin E, Kaul S, Eseaton PO. Analysis of hidradenitis suppurativa hospitalizations: A report from the National Inpatient Sample database. J Am Acad Dermatol. 2021;85(5):1357–60. https://doi.org/10.1016/j.jaad.2020.10.083.

Article  PubMed  Google Scholar 

Midgette B, Garg A. Epidemiology of hidradenitis suppurativa and its comorbid conditions. J Am Acad Dermatol. 2024;91(6):S3–7. https://doi.org/10.1016/j.jaad.2024.09.013.

Article  PubMed  Google Scholar 

Bouazzi D, Andersen RK, Vinding GR, et al. The global hidradenitis suppurativa atlas methodology: combining global proportions in a pooled analysis. Dermatology. 2024;240(3):369–75. https://doi.org/10.1159/000536389.

Article  PubMed  Google Scholar 

Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2017;77(1):118–22. https://doi.org/10.1016/j.jaad.2017.02.005.

Article  PubMed  Google Scholar 

Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019;9(9):e030579. https://doi.org/10.1136/bmjopen-2019-030579.

Article  PubMed  PubMed Central  Google Scholar 

Needham M. Inpatient management of hidradenitis suppurativa: a Delphi consensus study. Cutis. 2024;113(6):251–4. https://doi.org/10.12788/cutis.1027.

Article  PubMed  Google Scholar 

Hurley H. In: Roenigk RK, Roenigk Jr HH, editors. Dermatologic surgery: Principles and practice. 1st ed. Marcel Dekker; 1989. p. 729–39.

Google Scholar 

Koerts NDK, Bouwman K, Prens LM, Horváth B. Assessment tools and phenotype classification for hidradenitis suppurativa. Clin Dermatol. 2023;41(5):601–10. https://doi.org/10.1016/j.clindermatol.2023.08.016.

Article  PubMed  Google Scholar 

Kimball AB, Jemec GBE, Alavi A, et al. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Lancet Lond Engl. 2023;401(10378):747–61. https://doi.org/10.1016/S0140-6736(23)00022-3.

Article  CAS  Google Scholar 

LeWitt TM, Mammis-Gierbolini A, Parnell M, et al. International consensus definition of disease flare in hidradenitis suppurativa. Br J Dermatol. 2022;187(5):785–7. https://doi.org/10.1111/bjd.21647.

Article  PubMed  PubMed Central  Google Scholar 

Weber I, Giefer J, Martin KL. Effects of exercise and dietary modifications on hidradenitis Suppurativa: a systematic review. Am J Clin Dermatol. 2023;24(3):343–57. https://doi.org/10.1007/s40257-023-00756-w.

Article  PubMed  Google Scholar 

Frew JW. Intrinsic factors in the pathogenesis of hidradenitis suppurativa: Genetics, hormones, and the microbiome. J Am Acad Dermatol. 2024;91(6):S12–6. https://doi.org/10.1016/j.jaad.2024.08.052.

Article  PubMed  CAS  Google Scholar 

Frew JW. Unravelling the complex pathogenesis of hidradenitis suppurativa. Br J Dermatol. 2025;192(Supplement_1):i3–i14. https://doi.org/10.1093/bjd/ljae238.

Article  PubMed  Google Scholar 

Nielsen VW, Thomsen SF, Naik HB. Hidradenitis suppurativa pathogenesis: extrinsic factors. J Am Acad Dermatol. 2024;91(6):S17–21. https://doi.org/10.1016/j.jaad.2024.07.1524.

Article  PubMed  CAS  Google Scholar 

Chopra D, Arens RA, Amornpairoj W, et al. Innate immunity and microbial dysbiosis in hidradenitis suppurativa – vicious cycle of chronic inflammation. Front Immunol. 2022;13:960488. https://doi.org/10.3389/fimmu.2022.960488.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Maskan Bermudez N, Elman SA, Kirsner RS, Lev-Tov H. Management of hidradenitis suppurativa in the inpatient setting: a clinical guide. Arch Dermatol Res. 2025;317(1):202. https://doi.org/10.1007/s00403-024-03622-9.

Article  PubMed  PubMed Central  Google Scholar 

Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2019;81(1):76–90. https://doi.org/10.1016/j.jaad.2019.02.067.

Article  PubMed  PubMed Central  Google Scholar 

Garg A, Malviya N, Strunk A, et al. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2022;86(5):1092–101. https://doi.org/10.1016/j.jaad.2021.01.059.

Article  PubMed  Google Scholar 

Daoud M, Suppa M, Benhadou F, et al. Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data. Front Med. 2023;10:1145152. https://doi.org/10.3389/fmed.2023.1145152.

Article  Google Scholar 

Charrow A, Santiago-Soltero K, Porter M. Biologics in hidradenitis suppurativa: progress and new directions. J Am Acad Dermatol. 2024;91(6):S27–30. https://doi.org/10.1016/j.jaad.2024.09.027.

Article  PubMed  CAS  Google Scholar 

Taylor MT, Orenstein LAV, Barbieri JS. Pain severity and management of hidradenitis suppurativa at US emergency department visits. JAMA Dermatol. 2021;157(1):115. https://doi.org/10.1001/jamadermatol.2020.4494.

Article  PubMed  Google Scholar 

Dagenet CB, Lee KH, Sayed C, Hsiao JL, Shi VY. Comprehensive and updated algorithm of hidradenitis suppurativa management from the experts. Am J Clin Dermatol. Published online April 3, 2025. https://doi.org/10.1007/s40257-025-00940-0.

Holgersen N, Nielsen VW, Rosenø NAL, et al. Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa. JAAD Int. 2024;15:170–8. https://doi.org/10.1016/j.jdin.2024.03.002.

Article  PubMed  PubMed Central  Google Scholar 

Wortsman X, Alfageme F, Dini V, et al. International consensus statement on the use of ultrasound in hidradenitis suppurativa. J Eur Acad Dermatol Venereol. Published online February 18, 2025. https://doi.org/10.1111/jdv.20600.

Wortsman X. Strong validation of ultrasound as an imaging biomarker in hidradenitis suppurativa. Br J Dermatol. 2021;184(4):591–2. https://doi.org/10.1111/bjd.19433.

Article  PubMed  CAS  Google Scholar 

Mendes-Bastos P, Martorell A, Bettoli V, Matos AP, Muscianisi E, Wortsman X. The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: a narrative review. Br J Dermatol. 2023;188(5):591–600. https://doi.org/10.1093/bjd/ljad028.

Article  PubMed  Google Scholar 

Zacharias N. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. 2010;145(5):452. https://doi.org/10.1001/archsurg.2010.50.

Article  PubMed  Google Scholar 

Jørgensen AR, Thomsen SF, Karmisholt KE, Ring HC. Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn’s disease. Exp Dermatol. 2020;29(2):118–23. https://doi.org/10.1111/exd.14036.

Article  PubMed  CAS  Google Scholar 

Midgette B, Garg A. Comorbidities and quality of life in hidradenitis suppurativa. Dermatol Clin. 2025;43(2):173–8. https://doi.org/10.1016/j.det.2024.12.003.

Article  PubMed  CAS  Google Scholar 

Gold DA, Reeder VJ, Mahan MG, Hamzavi IH. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2014;70(4):699–703. https://doi.org/10.1016/j.jaad.2013.11.014.

Article  PubMed  Google Scholar 

Reddy S, Strunk A, Jemec GBE, Garg A. Incidence of myocardial infarction and cerebrovascular accident in patients with hidradenitis suppurativa. JAMA Dermatol. 2020;156(1):65. https://doi.org/10.1001/jamadermatol.2019.3412.

Article  PubMed  Google Scholar 

Garg A, Birabaharan M, Strunk A. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2018;79(1):71–6. https://doi.org/10.1016/j.jaad.2018.01.014.